Diapositive 1

Previous Page

Next Page

Page Background

Influence of p16/HPV on RT outcome in HNSCC

Loco-regional tumour control

Disease-specific survival

Overall survival

DAHANCA 5 (N=156)

0.44 (0.28 - 0.68)

0.35 (0.19 - 0.64)

0.36 (0.20 - 0.64)

Lassen 2009